17 Comments
Mar 5, 2022Liked by Alexandros Marinos

Given the number of believers there are in ivermectin, some of whom are scientifically literate, it's a bit surprising there hasn't been crowd funding for a large trial of IVM to be conducted by an independent body of top researchers. This points to an opening in the space of funding mechanisms that are out there, I think. Imagine if every person curious about IVM had been able to donate a few dollars early on easily, with just a few clicks on a website..

Expand full comment

Great writeup, thank you! I'm so sick of the anti ivermectin garbage from shills, it really just exposes how corrupt our whole medical industry is. We need new regulations to separate independent drug trial researchers from ANY kind of big pharma money, funded by taxpayers and elected positions by the people. We will just continue to get medical fraud with our current system and the revolving CDC/FDA/Big pharma door

Expand full comment

What would make them hesitate? The possibility that it showed that Ivermectin was a fairly reliable (not 100%, but fairly good %) cure for Covid-19? I know nothing more damning than if a cure that was being promoted but whose promoters were publicly shamed and demonized, and the cure itself suppressed/deshelved as ineffective or harmful, actually turned out to have been a cheap and easy cure and end-all for the pandemic. But I think an increasing number of people are starting to suspect the machinations behind 2020 and Big Pharma's role.

Expand full comment

Together we will ignore any findings which means you won't buy more vaccines

Expand full comment

Gideon M-K has written a recent update on Ivermectin.

A link is here:

https://gidmk.medium.com/the-jury-is-still-out-on-ivermectin-7d0a1895549

Interestingly, he includes a forest plot with only the agreed trials. He gives the Together trial a weighting of 33%. Fonseca gets 34%, Gonzalez 10%, the rest single figures.

So obviously he believed the Together trial is very worthwhile in its current form.

Even with this weighting, his forest plot still shows a small benefit to Ivermectin

Expand full comment

I may be missing something, but when I looked up the NCT, Ivm was in the title but not in the study design? Is it a post hoc thing? https://www.clinicaltrials.gov/ct2/show/NCT04727424

Expand full comment